View all cases
- Case details
- StatusSettledActionProcedural applicationCategoryOther procedural
- Parties
- Claimants
- Abbott Diabetes Care Inc.Operating co.
Representatives- Roland Küppers-Taylor Wessing
- Alexander Rubusch-Taylor Wessing
Respondents- Sibio Technology LimitedOperating co.
- Umedwings Netherlands B.V.Operating co.
Representatives- Thomas Gniadek-Simmons & Simmons
- Division
- Dusseldorf LD
- Technology
- InstrumentsMedical technology
- Language
- —
- First decided
- Jul 3, 2024
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Dusseldorf LD | Locked |
| Judge Berenice Thom | Locked |
| Judge Mélanie Bessaud | Locked |
| Judge Renaud Fulconis | Locked |
At the UPC: Abbott Group (67 cases)·Sibio Technology Limited (15 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 4 other proceedings
UPC CFI 3601/2026·UPC CoA 162/2026·UPC CFI 1086/2026·UPC CFI 133/2024
4 other defendants litigating the same or a related patent
UPC CFI 865/2026·UPC CFI 830/2025·CC 14848/2024·UPC CFI 430/2023
Start a free trial to see how each one ended.
More cases: Dusseldorf LD·2024
Decisions
- 2024-07-03
Summary: Order by Düsseldorf Local Division (UPC_CFI_133/2024, 3 July 2024) confirming settlement between Abbott Diabetes Care Inc. and Sibio/Umedwings under R. 365.1(2) RoP in provisional measures proceedings over EP 2 393 417. A 20% reimbursement of court fees was ordered, the settlement having been reached at the oral hearing stage.
Show the legal issues (3)
- Confirmation of settlement (R. 365.1 RoP)
- Court fee reimbursement (R. 370.9(c)(iii) RoP)
- Provisional measures proceedings
Documents
- 8B32B3D4D19E563332DA13812144CEE7_en.pdf2024-07-03EN